Jin-Shing Chen Selected Research

Adenocarcinoma of Lung

4/2024	Proteomic profiling of tumor microenvironment and prognosis risk prediction in stage I lung adenocarcinoma.
2/2024	Dual-energy computed tomography for evaluating nodal staging in lung adenocarcinoma: correlation with surgical pathology.
1/2024	Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib.
11/2023	CT-Based Deep-Learning Model for Spread-Through-Air-Spaces Prediction in Ground Glass-Predominant Lung Adenocarcinoma.
1/2023	Clinicopathological Features and Significance of Epidermal Growth Factor Receptor Mutation in Surgically Resected Early-Stage Lung Adenocarcinoma.
1/2023	Salvage Surgery for Advanced Lung Adenocarcinoma After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment.
1/2023	Tissue Proteogenomic Landscape Reveals the Role of Uncharacterized SEL1L3 in Progression and Immunotherapy Response in Lung Adenocarcinoma.
1/2023	Association of smoking and ALK tyrosine-kinase inhibitors on overall survival in treatment-naïve ALK-positive advanced lung adenocarcinoma.
1/2022	Treatment Effectiveness and Tolerability of Long-term Adjuvant First- and Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor at Different Doses in Patients With Stage IIA-IIIB Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Retrospective Study.
1/2022	Novel Genetic Prognostic Signature for Lung Adenocarcinoma Identified by Differences in Gene Expression Profiles of Low- and High-Grade Histological Subtypes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin-Shing Chen Research Topics

Disease

54	Neoplasms (Cancer) 04/2024 - 06/2003
28	Lung Neoplasms (Lung Cancer) 04/2024 - 11/2004
24	Pneumothorax 01/2024 - 01/2004
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 12/2011
14	Adenocarcinoma of Lung 04/2024 - 10/2015
8	Neoplasm Metastasis (Metastasis) 01/2024 - 06/2003
7	Hemorrhage 09/2017 - 12/2011
6	Blister (Bulla) 01/2024 - 01/2004
6	Infections 12/2017 - 07/2007
5	Thymoma (Thymic Carcinoma) 01/2022 - 01/2014
5	Hypoxia (Hypoxemia) 01/2014 - 05/2009
5	Esophageal Neoplasms (Esophageal Cancer) 02/2013 - 01/2005
4	Empyema 01/2020 - 12/2003
4	Pulmonary Hypertension 09/2017 - 05/2007
4	Chest Pain (Chest Pains) 03/2012 - 01/2004
3	Wounds and Injuries (Trauma) 01/2023 - 02/2014
3	Pain (Aches) 01/2020 - 12/2011
2	Respiratory Insufficiency (Respiratory Failure) 02/2024 - 01/2009
2	Cough 01/2022 - 01/2014
2	Respiratory Sounds (Crackle) 01/2021 - 02/2019
2	Pulmonary Atelectasis 02/2019 - 01/2014
2	Postoperative Pain 01/2018 - 04/2003
2	Fever (Fevers) 01/2017 - 12/2003
2	Tachypnea 01/2014 - 08/2012
2	Pulmonary Arterial Hypertension 05/2009 - 02/2008
2	Familial Primary Pulmonary Hypertension 07/2007 - 01/2005
2	Carcinogenesis 01/2005 - 06/2003
2	Breast Neoplasms (Breast Cancer) 06/2004 - 06/2003
1	Actinomycosis 01/2024
1	Hypotension (Low Blood Pressure) 10/2023
1	Thoracic Injuries (Chest Injury) 01/2023
1	Rib Fractures (Rib Fracture) 01/2023
1	Malnutrition (Nutritional Deficiencies) 12/2022
1	COVID-19 01/2022
1	Malaria 01/2022

Drug/Important Bio-Agent (IBA)

15	ErbB Receptors (EGF Receptor)IBA 01/2024 - 07/2011
11	Tyrosine Kinase InhibitorsIBA 01/2024 - 07/2015
8	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2004
6	Anesthetics (Anesthetic Agents)IBA 07/2020 - 01/2014
6	Minocycline (Cyclops)FDA LinkGeneric 07/2014 - 01/2004
5	Carcinoembryonic AntigenIBA 03/2022 - 10/2014
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 12/2003
4	RNA (Ribonucleic Acid)IBA 10/2017 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 06/2004
3	Biocompatible Materials (Biomaterials)IBA 01/2024 - 11/2017
3	xylometazoline (stas)IBA 11/2023 - 12/2018
3	Coloring Agents (Dyes)IBA 01/2019 - 10/2016
3	MicroRNAs (MicroRNA)IBA 01/2017 - 09/2011
3	Analgesics (Analgesic Drugs)IBA 12/2014 - 01/2004
3	Meperidine (Pethidine)FDA LinkGeneric 03/2012 - 04/2003
2	caprolactoneIBA 01/2024 - 01/2024
2	osimertinibIBA 01/2024 - 01/2022
2	Oxygen (Dioxygen)IBA 09/2020 - 09/2017
2	AfatinibIBA 01/2019 - 01/2017
2	sulfan blue (patent blue V)IBA 01/2019 - 10/2016
2	Gefitinib (Iressa)FDA Link 01/2019 - 01/2017
2	CytokinesIBA 12/2017 - 04/2010
2	Codon (Codons)IBA 05/2016 - 02/2006
2	SurvivinIBA 04/2011 - 11/2004
2	Simvastatin (Zocor)FDA LinkGeneric 03/2011 - 05/2009
2	MonocrotalineIBA 03/2011 - 05/2009
1	IodineIBA 02/2024
1	Dexmedetomidine FDA Link 02/2024
1	Opioid Analgesics (Opioids)IBA 02/2024
1	LigandsIBA 01/2024
1	Remifentanil (Ultiva)FDA Link 10/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	ProteomeIBA 01/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2022
1	CateninsIBA 10/2022

Therapy/Procedure

16	Therapeutics 01/2024 - 06/2003
14	Segmental Mastectomy (Lumpectomy) 08/2022 - 10/2013
13	Pleurodesis 01/2024 - 01/2004
13	Length of Stay 01/2023 - 04/2003
11	Chest Tubes (Chest Tube) 09/2017 - 12/2003
8	One-Lung Ventilation 09/2020 - 12/2011
7	Epidural Anesthesia 01/2022 - 12/2011
7	General Anesthesia 01/2022 - 12/2011
7	Thoracotomy 09/2017 - 03/2006
5	Anesthesia 02/2020 - 04/2010
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
3	Radiotherapy 01/2024 - 04/2013
3	Transplantation 10/2022 - 02/2008
3	Minimally Invasive Surgical Procedures 08/2022 - 12/2017
3	Debridement 10/2016 - 12/2003
3	Pneumonectomy (Lung Volume Reduction) 10/2016 - 04/2013
3	Extracorporeal Membrane Oxygenation 01/2012 - 02/2008
3	Esophagectomy 07/2011 - 01/2005
2	Injections 01/2021 - 03/2012
2	Analgesia 02/2019 - 03/2013
2	Thymectomy 01/2018 - 01/2014
2	Operative Time 01/2018 - 04/2010
2	Thoracostomy 01/2017 - 01/2012
2	Catheters 01/2017 - 04/2013
2	Lung Transplantation 04/2009 - 01/2009
1	Oral Hygiene (Dental Hygiene) 01/2024
1	Traction 01/2024
1	Immunotherapy 01/2023
1	Conservative Treatment 01/2023
1	Personal Protective Equipment 01/2022